Lieven Denis Herwig Declercq

Title: The Innovations of Lieven Denis Herwig Declercq

Introduction

Lieven Denis Herwig Declercq is a notable inventor based in Bierbeek, Belgium. He has made significant contributions to the field of medical imaging, particularly in the development of tau PET imaging ligands. With a total of two patents to his name, Declercq's work is paving the way for advancements in the diagnosis and understanding of neurodegenerative diseases.

Latest Patents

Declercq's latest patents focus on novel, selective radiolabelled tau ligands that are instrumental for imaging and quantifying tau aggregates using positron-emission tomography (PET). These inventions not only encompass the compounds themselves but also include compositions that utilize these compounds for imaging tissues or subjects, both in vitro and in vivo. The processes for preparing these compounds and their precursors are also covered in his patents, showcasing a comprehensive approach to medical imaging technology.

Career Highlights

Declercq is currently associated with Janssen Pharmaceutica NV, a leading pharmaceutical company known for its innovative research and development in healthcare. His work at Janssen has allowed him to focus on cutting-edge technologies that enhance diagnostic capabilities in the medical field.

Collaborations

Throughout his career, Declercq has collaborated with esteemed colleagues such as José Ignacio Andrés-Gil and Guy Maurits R Bormans. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their collective work.

Conclusion

Lieven Denis Herwig Declercq's contributions to the field of medical imaging through his innovative patents are noteworthy. His work not only advances the understanding of tau aggregates but also plays a crucial role in improving diagnostic techniques for neurodegenerative diseases.